title: The functional Val158Met polymorphism of COMT predicts interindividual differences in brain alpha oscillations in young men.
abstract: Individual patterns of the electroencephalogram (EEG) in wakefulness and sleep are among the most heritable traits in humans, yet distinct genetic and neurochemical mechanisms underlying EEG phenotypes are largely unknown. A functional polymorphism in the gene encoding catechol-O-methyltransferase (COMT), an enzyme playing an important role in cortical dopamine metabolism, causes a common substitution of methionine (Met) for valine (Val) at codon 158 of COMT protein. Val allele homozygotes exhibit higher COMT activity and lower dopaminergic signaling in prefrontal cortex than Met/Met homozygotes. Evidence suggests that this polymorphism affects executive functions in healthy individuals. We hypothesized that it also modulates functional aspects of EEG in wakefulness and sleep. EEG recordings were conducted twice on separate occasions in 10 Val/Val and 12 Met/Met allele carriers (all men) in wakefulness, and in baseline and recovery sleep before and after 40 h prolonged waking. During sleep deprivation, subjects received placebo and modafinil in randomized, cross-over manner. We show that the Val158Met polymorphism predicts stable and frequency-specific, interindividual variation in brain alpha oscillations. Alpha peak frequency in wakefulness was 1.4 Hz slower in Val/Val genotype than in Met/Met genotype. Moreover, Val/Val allele carriers exhibited less 11-13 Hz activity than Met/Met homozygotes in wakefulness, rapid-eye-movement (REM) sleep, and non-REM sleep. This difference was resistant against the effects of sleep deprivation and modafinil. The data demonstrate that mechanisms involving COMT contribute to interindividual differences in brain alpha oscillations, which are functionally related to executive performance such as counting tendency on a random number generation task in young adults.
authors.affiliation: Institute of Pharmacology and Toxicology, University of Zürich, 8057 Zürich, Switzerland.
authors.forename: Sereina
authors.initials: S
authors.lastname: Bodenmann
authors.forename: Thomas
authors.initials: T
authors.lastname: Rusterholz
authors.forename: Roland
authors.initials: R
authors.lastname: Dürr
authors.forename: Claudia
authors.initials: C
authors.lastname: Stoll
authors.forename: Valérie
authors.initials: V
authors.lastname: Bachmann
authors.forename: Eva
authors.initials: E
authors.lastname: Geissler
authors.forename: Karin
authors.initials: K
authors.lastname: Jaggi-Schwarz
authors.forename: Hans-Peter
authors.initials: HP
authors.lastname: Landolt
mesh_terms: D000367:Age Factors; D000513:Alpha Rhythm / Q000187:drug effects / Q000379:methods; D001559:Benzhydryl Compounds / Q000008:administration & dosage; D002394:Catechol O-Methyltransferase / Q000235:genetics / Q000502:physiology*; D018592:Cross-Over Studies; D006801:Humans; D008297:Male; D008715:Methionine / Q000235:genetics*; D000077408:Modafinil; D011110:Polymorphism, Genetic / Q000187:drug effects; D011237:Predictive Value of Tests; D011446:Prospective Studies; D012893:Sleep Wake Disorders / Q000201:enzymology / Q000235:genetics; D014633:Valine / Q000235:genetics*; D014851:Wakefulness / Q000235:genetics; D055815:Young Adult
chemical_list: D001559:Benzhydryl Compounds; D008715:Methionine; D002394:Catechol O-Methyltransferase; D014633:Valine; D000077408:Modafinil